ELES Semiconductor Equipment (BIT:ELES) Full Year 2023 Results
Key Financial Results
- Revenue: €33.7m (up 29% from FY 2022).
- Net income: €799.0k (up 22% from FY 2022).
- Profit margin: 2.4% (down from 2.5% in FY 2022). The decrease in margin was driven by higher expenses.
All figures shown in the chart above are for the trailing 12 month (TTM) period
ELES Semiconductor Equipment Earnings Insights
Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Semiconductor industry in Europe.
Performance of the market in Italy.
The company's shares are down 6.9% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 4 warning signs for ELES Semiconductor Equipment you should be aware of, and 2 of them shouldn't be ignored.
Valuation is complex, but we're here to simplify it.
Discover if ELES Semiconductor Equipment might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BIT:ELES
ELES Semiconductor Equipment
Designs, manufactures, and sells test equipment, fixtures, solutions, and services for the semiconductor industry in Italy.
Excellent balance sheet with reasonable growth potential.